Spots Global Cancer Trial Database for Breast MRI for Neaodjuvant Chemotherapy Response Prediction and Evaluation in Breast Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Breast MRI for Neaodjuvant Chemotherapy Response Prediction and Evaluation in Breast Cancer
Official Title: Breast MRI for Neaodjuvant Chemotherapy Response Prediction and Evaluation in Breast Cancer, With Focus on Background Parenchymal Enhancement
Study ID: NCT03580837
Conditions
Interventions
Study Description
Brief Summary: The aim of this retrospective study is to evaluate the value of pre-treatment and post-treatment multimodality MRI study, including quantitative evaluation of background parenchymal enhancement, for response prediction and evaluation. This study will include 100 patients treated in a single institution between 2011 and 2016
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Service Imagerie 1, Strasbourg, , France
Contact Details
Name: Sébastien MOLIERE, MD
Affiliation: University Hospital, Strasbourg, France
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
